Cabot Marijuana Investor Update
I’m making four changes to the portfolio today.
Read More
vape pen lung disease
Read More
vape pen lung disease Archives
Cabot Marijuana Investor Update
It’s been a tough few months for cannabis investors, but no downtrend lasts forever, and yesterday’s blast-off by Aphria (APHA), which sparked buying across the sector, is a sign that the worst has almost certainly passed.
Read More
Cabot Marijuana Investor Update
Yesterday was the worst day of the year for cannabis stocks, with HEXO (no longer in our portfolio) leading the way down with a plunge of 22.5% after the company announced that revenue for the fiscal fourth quarter, ended July, would be $14.5 $16.5...
Read More
Cabot Marijuana Investor Update
The cannabis sector has been trending down since the end of March, giving back its spectacular gains from the start of the year, and until now I’ve remained optimistic about our stocks, partially because of their outstanding fundamental growth metrics but also because two...
Read More
Cabot Marijuana Investor Update
In the broad market, all is well, as all trend-following indicators are positive, and the number of stocks hitting new lows has been minuscule in recent days.
Read More
The Truth About Vape Pen Lung Disease
Major media outlets are trying to scare you about vape pen lung disease. Here's the real truth about it - and what's next for marijuana stocks.
Read More
Cabot Marijuana Investor Update
One major factor in investing, particularly in small stocks and young sectors where growing pains are still the norm, is sentiment. Good sentiment can take a sector to extreme highs—as it has done for the marijuana sector at every major legalization milepost.
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up